NEWBURY STREET PRACTICE — All Prescriptions & Medications — Page 4
Practice Code: K84019 | WANTAGE, OX12 9BN
Showing results 151-200 of 654
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Umeclidinium bromide/vilanterol | 275 | 349 | £10.8K | +41.0% ▲ |
| Prochlorperazine maleate | 272 | 11.7K | £832 | +34.6% ▲ |
| 271 | 2,010 | £857 | +29.7% ▲ | |
| Cefalexin | 268 | 11.1K | £709 | +130.4% ▲ |
| Oxybutynin | 267 | 17.3K | £2.5K | +40.2% ▲ |
| Methylprednisolone acetate | 263 | 410 | £1.6K | +127.8% ▲ |
| Loratadine | 262 | 13.1K | £289 | +25.4% ▲ |
| Ibuprofen | 262 | 41.4K | £837 | +115.0% ▲ |
| Pancreatin | 257 | 69.1K | £16.9K | +131.2% ▲ |
| Carbomer 940/980 | 255 | 3,630 | £647 | +67.5% ▲ |
| Oxycodone hydrochloride | 254 | 30.5K | £3.0K | -0.8% vs avg |
| Anastrozole | 251 | 12.2K | £459 | +175.7% ▲ |
| Cyclizine hydrochloride | 245 | 13.4K | £470 | +51.9% ▲ |
| Risedronate sodium | 245 | 1,468 | £401 | +102.0% ▲ |
| Powder extensively hydrolysed formula (0913101) | 244 | 590.8K | £16.6K | +238.7% ▲ |
| Insulin degludec | 242 | 1,271 | £12.6K | +120.2% ▲ |
| Enalapril maleate | 240 | 15.4K | £643 | +33.6% ▲ |
| Rivaroxaban | 240 | 11.4K | £7.1K | -60.8% ▼ |
| Co-careldopa (Carbidopa/levodopa) | 239 | 33.6K | £2.3K | +5.8% ▲ |
| Glyceryl trinitrate | 238 | 959 | £671 | +0.6% vs avg |
| Mometasone furoate | 238 | 14.8K | £1.4K | +78.0% ▲ |
| Pravastatin sodium | 237 | 12.0K | £555 | -27.0% ▼ |
| Ispaghula husk | 235 | 14.2K | £2.4K | +78.4% ▲ |
| Promethazine hydrochloride | 232 | 11.2K | £1.2K | -35.1% ▼ |
| 227 | 31.0K | £1.3K | +73.3% ▲ | |
| Insulin detemir | 224 | 1,650 | £13.9K | +186.0% ▲ |
| Rivastigmine | 223 | 9,985 | £4.8K | +224.1% ▲ |
| Sacubitril/valsartan | 222 | 14.1K | £23.1K | -7.3% ▼ |
| Letrozole | 220 | 9,240 | £817 | +17.8% ▲ |
| Dexamethasone | 219 | 1,540 | £960 | +27.4% ▲ |
| Quinine sulfate | 217 | 9,716 | £1.6K | -25.0% ▼ |
| Aripiprazole | 216 | 6,982 | £1.1K | -15.1% ▼ |
| Biphasic insulin aspart | 211 | 2,860 | £16.7K | +107.8% ▲ |
| Hydroxychloroquine sulfate | 207 | 9,646 | £792 | +6.9% ▲ |
| Betahistine hydrochloride | 206 | 19.1K | £646 | -13.7% ▼ |
| Nortriptyline | 203 | 18.0K | £3.5K | +39.5% ▲ |
| Calcipotriol | 203 | 18.7K | £9.7K | +19.2% ▲ |
| Lymecycline | 201 | 11.1K | £1.3K | +67.1% ▲ |
| Glucose | 201 | 35.7K | £3.2K | +286.5% ▲ |
| Bisacodyl | 194 | 11.4K | £630 | +48.0% ▲ |
| Co-beneldopa (Benserazide/levodopa) | 192 | 39.6K | £2.4K | +27.0% ▲ |
| Vitamin B compound | 192 | 11.5K | £340 | +37.8% ▲ |
| Meloxicam | 192 | 10.4K | £266 | +190.3% ▲ |
| Lorazepam | 191 | 6,544 | £2.8K | +34.0% ▲ |
| Hypromellose | 187 | 2,790 | £731 | +41.1% ▲ |
| Isophane insulin | 186 | 1,465 | £6.2K | +76.2% ▲ |
| Fentanyl | 184 | 1,582 | £3.8K | +79.6% ▲ |
| Lithium carbonate | 182 | 8,168 | £1.2K | +43.5% ▲ |
| 177 | 1,686 | £737 | -29.1% ▼ | |
| Denosumab | 175 | 175 | £30.2K | +543.1% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.